We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Dermatopathology Specimens Examined by Smartphone-Based Microscopy

By LabMedica International staff writers
Posted on 01 Feb 2016
The incorporation of high-resolution cameras into smartphones has allowed for a variety of medical applications including the use of lens attachments that provide telescopic, macroscopic, and dermatoscopic data. More...


Skin biopsy and the pathologic information that it provides is foundational to the diagnosis and management of dermatologic disease. However, a lack of expertise in dermatopathologic-specimen interpretation in resource-poor areas may impede timely diagnosis and treatment.

Pathologists at the University of Texas Houston Health Science Center (TX, USA) and their collaborators constructed a mobile phone microscope by using a modified method and a 3-mm-diameter sapphire ball lens purchased from Edmund Optics (Barrington, NJ, USA). A total of 1,130 consecutive dermatopathology specimens from mostly community dermatologists were evaluated. The performance characteristics of the smartphone platform were calculated by using conventional light microscopy as the gold standard. The sensitivity and specificity for the diagnosis of melanoma, non-melanoma skin cancers, and other miscellaneous conditions by the phone microscopy platform, as compared with traditional light microscopy, were calculated.

All excisional 101 specimens were excluded because the diagnosis was previously established. Among the 1,021 specimens, 930 (91.1%) were shave biopsies and 91 (8.9%) were punch biopsies from 763 different patients. For 136 basal cell carcinoma cases, the sensitivity and specificity of smartphone microscopy were 95.6% and 98.1%, respectively. The sensitivity and specificity for 94 squamous cell carcinoma cases were 89.4% and 97.3%, respectively. The lowest sensitivity was found in the 15 melanomas at 60%, although the specificity was high at 99.1%. The accuracy of diagnosis of inflammatory conditions and other neoplasms was variable.

The authors concluded that their study demonstrated the potential for a high-performing, low-cost smartphone microscopy system in the diagnosis of cutaneous disease. Studies with larger sample sizes of pigmented lesions, non-melanoma skin cancer (NMSC) subtypes, and dermatologic infections could help improve this modality for point-of-care diagnostics in resource-poor settings. The study was published in the January 2016 issue of the journal Archives of Pathology & Laboratory Medicine.

Related Links:

University of Texas Houston Health Science 
Edmund Optics



New
Gold Member
Aspiration System
VACUSAFE
New
Gold Member
STI Test
Vivalytic MG, MH, UP/UU
New
Immunofluorescence Analyzer
IFA System
New
HPV Test
Allplex HPV28 Detection
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Plasma pTau217 testing can predict future amyloid accumulation and cognitive decline in cognitively healthy older adults (photo courtesy of Shutterstock)

Blood Test Predicts Alzheimer Disease Risk Before Imaging Changes and Symptoms

Alzheimer's disease often advances silently for years, making timely risk stratification difficult in routine practice. Current approaches to detect pathology can involve lumbar puncture or positron emission... Read more

Industry

view channel
Image: Pathlight combines WGS and dPCR to identify and longitudinally track large‑scale genomic changes, known as structural variants (photo courtesy of SAGA Diagnositcs)

Roche Affiliate Expands MRD Portfolio with SAGA Acquisition

Foundation Medicine, Inc., an independent affiliate of Roche, announced plans to expand its monitoring portfolio with SAGA Diagnostics’ Pathlight, a personalized, tumor-informed molecular residual disease... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.